Physician profile
Darrell R Smith
NPI 1427071331
$1,806.54
in general payments reported to CMS, 2019-2025
15 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.62 · 2020: $13.85 · 2021: $101 · 2022: $316 · 2023: $357 · 2024: $294 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,277 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,276.64 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $682.26 | 2022-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $330.24 | 2021-2025 | Dupixent |
| Optinose US, INC. | $231.03 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $161.99 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $97.77 | 2021-2025 | Keytruda |
| Genzyme Corporation | $64.13 | 2024 | |
| Glaxosmithkline, LLC. | $53.65 | 2023-2024 | Nucala |
| Kaleo, INC. | $40.29 | 2022-2024 | Auvi-Q |
| Alk-Abello, INC | $29.04 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $25.77 | 2025 | Neffy |
| Paratek Pharmaceuticals, INC. | $24.73 | 2025 | Xhance |
| Karl Storz Endoscopy-America | $24.38 | 2022 | |
| Medtronic, INC. | $15.41 | 2022 | |
| Davol INC. | $13.85 | 2020 | |
| Stryker Corporation | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.